Ipharma LLC

ipharma, the accredited common use center (cuc) for "biomedical services"​ of technopark "skolkovo"​, is a fast-growing innovative cro in russia and eaeu. our pipeline consists of over 40 clinical studies in oncology, virology, endocrinology, pulmonology, neurology, transplantology, etc. we provide agile clinical services in both early-phase and registration studies, as well as medical, regulatory, and pv expertise to ensure optimal timeline for your drug development. according to association of clinical studies organizations, ipharma has been ranked as a market leader of russian innovative drugs (acto analytical report #8 for 2013, #10 for 2014, and #12 for 2015). our mission is to contribute to progress of treating patients with socially significant and other important diseases by efficient organization of clinical studies and introduction of novel drugs to medical practice. advantages of working with ipharma: 1. medical and scientific expertise and access to top researchers and kols